Pfizer Calls Early End To Celebrex Safety Study In Children – NASDAQ

The study was undertaken to create a registry of long-term safety data for juvenile arthritis patients treated with Celebrex or other pain relievers known as non-selective, non-steroidal anti-inflammatory drugs, or non-selective NSAIDs.

Leave a Reply

Your email address will not be published. Required fields are marked *